Vision SCS F2

CGEM

Vision SCS F2 serves as 10% Owner at Cullinan Therapeutics, Inc. (CGEM). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$4.76M

Net Position

Net Seller

$4.76M

Companies Traded

CGEM

Active Period

May 2022 – Aug 2022

2 total trades

Most Recent

Sell CGEM

Aug 2, 2022 · $711.7K

Vision SCS F2's Insider Trading at Cullinan Therapeutics, Inc. (CGEM)

Buys

0 · $0.00

Sells

2 · $4.76M

Total Shares Bought

Total Shares Sold

468,648

CGEM Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 2, 2022	Sell	49,910	$14.26	$711.7K	0
May 12, 2022	Sell	418,738	$9.66	$4.05M	0

Related Insiders

Jennifer Michaelson

officer: Chief Scientific Officer

CGEMSell · Mar 9, 2026

AHMED NADIM

President and CEO

CGEMSell · Feb 25, 2026

Jeffrey Alan Jones

officer: Chief Medical Officer

CGEMSell · Feb 25, 2026

SUMER JACQUELYN L

officer: Chief Legal Officer

CGEMSell · Feb 25, 2026

Mary Kay Fenton

Chief Financial Officer

CGEMSell · Feb 20, 2026

Explore More Insider Trading Data

CGEM Insider Trading Activity

View all insider trades at Cullinan Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity